Target intelligence / Profile preview

Ribosomal protein L29 pseudogene 2 (RPL29P2)

Target
RPL29P2
Molecular classification
Other
01

Overview

Ribosomal protein L29 pseudogene 2 (RPL29P2) is a non-functional pseudogene based on sequence homology to the functional ribosomal protein L29 (RPL29), which encodes a structural constituent of the large (60S) ribosomal subunit[1][2][8][9]. RPL29P2, as a pseudogene, does not produce a functional protein and is not involved in active biological processes or diseases, nor does it serve as a drug target or biomarker. Pseudogenes like RPL29P2 are considered genomic remnants of once-protein-coding genes that usually arise from retrotransposition events[8]. Because RPL29P2 is a pseudogene: - It lacks protein-coding ability and does not participate in cellular signal transduction, metabolism, or regulatory pathways[1][2][8]. - There are no known drugs or therapeutic agents that interact with this pseudogene, nor is it a recognized biomarker or source of safety concerns. - The existence of such pseudogenes can be informative in evolutionary studies and for the annotation of the human genome[8]. - The parent gene RPL29 is involved in ribosomal structure and protein synthesis, but the pseudogene RPL29P2 has no known direct biological or disease role[1][7][8]. There is no evidence or reference to RPL29P2 being misnamed, misspelled, or representing a real protein-coding or therapeutic target. It is correctly annotated and appropriately described as a pseudogene in major genomic resources[1][2][9].

Other names
RPL29_10_1510RPL29P2

Beyond the preview

Go deeper on Ribosomal protein L29 pseudogene 2 (RPL29P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L29 pseudogene 2 (RPL29P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call